Revive Therapeutics Total Debt vs. Price To Earning
| RVVTF Stock | USD 0.01 0.0003 5.00% |
For Revive Therapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Revive Therapeutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Revive Therapeutics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Revive Therapeutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Revive Therapeutics over time as well as its relative position and ranking within its peers.
Revive |
Revive Therapeutics Price To Earning vs. Total Debt Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Revive Therapeutics's current stock value. Our valuation model uses many indicators to compare Revive Therapeutics value to that of its competitors to determine the firm's financial worth. Revive Therapeutics is rated fifth in total debt category among its peers. It is rated second in price to earning category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Revive Therapeutics' earnings, one of the primary drivers of an investment's value.Revive Total Debt vs. Competition
Revive Therapeutics is rated fifth in total debt category among its peers. Total debt of Health Care industry is at this time estimated at about 1.44 Billion. Revive Therapeutics adds roughly 60,000 in total debt claiming only tiny portion of equities under Health Care industry.
Revive Price To Earning vs. Total Debt
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Revive Therapeutics |
| = | 60 K |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Revive Therapeutics |
| = | (4.10) X |
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Revive Price To Earning Comparison
Revive Therapeutics is currently under evaluation in price to earning category among its peers.
Revive Therapeutics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Revive Therapeutics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Revive Therapeutics will eventually generate negative long term returns. The profitability progress is the general direction of Revive Therapeutics' change in net profit over the period of time. It can combine multiple indicators of Revive Therapeutics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company was incorporated in 2012 and is headquartered in Toronto, Canada. Revive Therapeutics is traded on OTC Exchange in the United States.
Revive Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Revive Therapeutics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Revive Therapeutics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Revive Therapeutics' important profitability drivers and their relationship over time.
Use Revive Therapeutics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Revive Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revive Therapeutics will appreciate offsetting losses from the drop in the long position's value.Revive Therapeutics Pair Trading
Revive Therapeutics Pair Trading Analysis
The ability to find closely correlated positions to Revive Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Revive Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Revive Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Revive Therapeutics to buy it.
The correlation of Revive Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Revive Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Revive Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Revive Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Revive Therapeutics position
In addition to having Revive Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Monster Funds Thematic Idea Now
Monster Funds
Solid funds with above average long term performance indicators based on Macroaxis rating system. The Monster Funds theme has 33 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Monster Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Revive OTC Stock
To fully project Revive Therapeutics' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Revive Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Revive Therapeutics' income statement, its balance sheet, and the statement of cash flows.